missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human GALNT8 Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (42%), Rat (42%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-52964 (PA5-52964. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Probably catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor.
Specifications
Specifications
| Accession Number | Q9NY28 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 26290 |
| Name | Human GALNT8 Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | GalNAc transferase 8; GalNAc-T8; GALNT8; Polypeptide GalNAc transferase 8; polypeptide N-acetylgalactosaminyltransferase 8; pp-GaNTase 8; probable polypeptide N-acetylgalactosaminyltransferase 8; Protein-UDP acetylgalactosaminyltransferase 8; UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase 8; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) |
| Common Name | GALNT8 |
| Show More |